Free Trial

Plains GP (PAGP) Financials

Plains GP logo
$26.37 +0.22 (+0.84%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$26.42 +0.05 (+0.21%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Plains GP

Annual Income Statements for Plains GP

This table shows Plains GP's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
118 94 -731 334 331 -568 60 168 198 103 260
Consolidated Net Income / (Loss)
809 660 -41 2,107 2,062 -2,440 600 1,163 1,425 1,070 1,686
Net Income / (Loss) Continuing Operations
809 660 -41 2,107 2,062 -2,440 600 1,163 1,233 839 1,303
Total Pre-Tax Income
991 738 896 2,409 2,238 -2,607 712 1,409 1,362 963 1,395
Total Operating Income
1,258 990 1,147 2,272 1,980 -2,383 842 1,284 1,249 862 1,428
Total Gross Profit
3,426 2,949 3,238 4,262 4,217 2,859 3,574 4,166 3,399 3,727 3,829
Total Revenue
23,152 20,182 26,223 34,055 33,669 23,290 42,078 57,342 47,336 48,889 44,262
Operating Revenue
23,152 20,182 26,223 34,055 33,669 23,290 42,078 57,342 47,336 48,889 44,262
Total Cost of Revenue
19,726 17,233 22,985 29,793 29,452 20,431 38,504 53,176 43,937 45,162 40,433
Operating Cost of Revenue
19,726 17,233 22,985 29,793 29,452 20,431 38,504 53,176 43,937 45,162 40,433
Total Operating Expenses
2,168 1,959 2,091 1,990 2,237 5,242 2,732 2,882 2,150 2,865 2,401
Selling, General & Admin Expense
1,735 1,464 1,463 1,583 1,605 1,352 1,363 1,645 1,390 1,805 1,502
Depreciation Expense
433 515 519 521 604 656 777 968 912 901 953
Impairment Charge
- -20 109 -114 28 3,234 592 269 -152 159 -54
Total Other Income / (Expense), net
-267 -252 -251 137 258 -224 -130 125 113 101 -33
Interest Expense
443 480 510 431 425 436 425 405 386 382 467
Interest & Investment Income
183 195 290 575 659 173 276 749 397 467 413
Other Income / (Expense), net
-7.00 33 -31 -7.00 24 39 19 -219 102 16 21
Income Tax Expense
182 78 937 302 176 -167 112 246 129 124 92
Net Income / (Loss) Discontinued Operations
- - - - - - - - 192 231 383
Net Income / (Loss) Attributable to Noncontrolling Interest
691 566 690 1,773 1,731 -1,872 540 995 1,227 967 1,426
Basic Earnings per Share
- - ($5.03) $2.12 $1.97 ($3.06) $0.31 $0.86 $1.01 $0.52 $1.31
Weighted Average Basic Shares Outstanding
83M 99M 145M 158M 168M 186M 194M 194M 195M 197M 198M
Diluted Earnings per Share
- - ($5.03) $2.11 $1.96 ($3.07) $0.31 $0.86 $1.00 $0.51 $1.30
Weighted Average Diluted Shares Outstanding
83M 99M 145M 282M 170M 246M 194M 194M 239M 232M 233M
Weighted Average Basic & Diluted Shares Outstanding
83M 99M 145M 158M 182.14M 194.10M 194.19M 194.41M 197.12M 197.74M 197.90M

Quarterly Income Statements for Plains GP

This table shows Plains GP's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
42 39 33 -11 84 30 83 63 20 389 68
Consolidated Net Income / (Loss)
336 316 301 117 492 283 504 407 222 1,815 432
Net Income / (Loss) Continuing Operations
336 284 187 117 356 213 428 170 325 166 392
Total Pre-Tax Income
364 348 205 164 388 229 458 143 333 375 420
Total Operating Income
369 330 195 85 355 237 483 176 403 397 515
Total Gross Profit
1,078 919 916 1,174 960 884 993 702 977 1,137 1,143
Total Revenue
11,995 12,757 12,456 12,402 11,477 10,642 11,578 10,031 12,470 17,693 15,173
Operating Revenue
11,995 12,757 12,456 12,402 11,477 10,642 11,578 10,031 12,470 17,693 15,173
Total Cost of Revenue
10,917 11,838 11,540 11,228 10,517 9,758 10,585 9,329 11,493 16,556 14,030
Operating Cost of Revenue
10,917 11,838 11,540 11,228 10,517 9,758 10,585 9,329 11,493 16,556 14,030
Total Operating Expenses
709 589 721 1,089 605 647 510 526 574 740 628
Selling, General & Admin Expense
455 361 495 673 386 370 372 291 384 439 385
Depreciation Expense
254 226 226 258 232 235 230 226 243 242 235
Impairment Charge
0.00 2.00 0.00 158 -13 42 -92 9.00 -53 59 8.00
Total Other Income / (Expense), net
-5.00 18 10 79 33 -8.00 -25 -33 -70 -22 -95
Interest Expense
95 96 97 94 107 110 112 138 144 135 116
Interest & Investment Income
95 106 97 169 134 94 96 89 89 89 17
Other Income / (Expense), net
-5.00 8.00 10 4.00 6.00 8.00 -9.00 16 -15 24 4.00
Income Tax Expense
28 64 18 47 32 16 30 -27 8.00 209 28
Net Income / (Loss) Discontinued Operations
- 32 114 - 136 70 76 - -103 1,649 40
Net Income / (Loss) Attributable to Noncontrolling Interest
294 277 268 128 408 253 421 344 202 1,426 364
Basic Earnings per Share
$0.21 $0.20 $0.17 ($0.06) $0.42 $0.15 $0.42 $0.32 $0.10 $1.97 ($0.16)
Weighted Average Basic Shares Outstanding
197M 197M 197M 197M 198M 198M 198M 198M 198M 198M 198M
Diluted Earnings per Share
$0.21 $0.19 $0.17 ($0.06) $0.42 $0.15 $0.41 $0.32 $0.10 $1.97 ($0.16)
Weighted Average Diluted Shares Outstanding
197M 232M 197M 197M 197.74M 198M 233M 233M 197.90M 198M 198M
Weighted Average Basic & Diluted Shares Outstanding
197.25M 197.26M 197.47M 197.74M 197.74M 197.74M 197.89M 197.90M 197.90M 197.90M 198.10M

Annual Cash Flow Statements for Plains GP

This table details how cash moves in and out of Plains GP's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-374 20 -10 38 15 -21 393 -52 49 -104 -34
Net Cash From Operating Activities
1,347 718 2,496 2,604 2,500 1,510 1,991 2,404 2,722 2,484 2,931
Net Cash From Continuing Operating Activities
1,347 718 2,496 2,604 2,500 1,510 1,993 2,404 2,247 2,230 2,447
Net Income / (Loss) Continuing Operations
809 660 -41 2,107 2,062 -2,440 600 1,163 1,233 839 1,303
Consolidated Net Income / (Loss)
809 660 -41 2,107 2,062 -2,440 600 1,163 1,425 1,070 1,686
Net Income / (Loss) Discontinued Operations
- - - - - - - - 192 231 383
Depreciation Expense
433 515 519 521 604 656 777 968 912 901 953
Non-Cash Adjustments To Reconcile Net Income
107 30 167 -127 -218 3,670 781 302 3.00 311 134
Changes in Operating Assets and Liabilities, net
-2.00 -487 1,851 103 52 -376 -165 -29 99 179 57
Net Cash From Discontinued Operating Activities
- - - - - - - - 475 254 484
Net Cash From Investing Activities
-2,530 -1,273 -1,570 -813 -1,765 -1,093 386 -526 -702 -875 -3,439
Net Cash From Continuing Investing Activities
-2,530 -1,273 -1,570 -813 -1,765 -1,093 386 -526 -540 -705 -3,242
Purchase of Property, Plant & Equipment
-2,079 -1,334 -1,024 -1,634 -1,181 -738 -336 -455 -408 -448 -643
Acquisitions
-105 -282 -1,280 0.00 -50 -310 -32 -149 -425 -248 -2,651
Sale of Property, Plant & Equipment
5.00 654 1,083 1,334 77 429 881 60 328 11 81
Other Investing Activities, net
-351 -311 -370 -513 -611 -474 -127 18 -35 -20 -29
Net Cash From Discontinued Investing Activities
- - - - - - - - -162 -170 -197
Net Cash From Financing Activities
813 571 -940 -1,753 -717 -430 -1,979 -1,927 -1,971 -1,702 474
Net Cash From Continuing Financing Activities
813 571 -940 -1,753 -717 -430 -1,979 -1,927 -1,971 -1,702 474
Repayment of Debt
-605 -1,336 -2,040 -143 -960 -117 -906 -799 -755 -839 -1,616
Repurchase of Preferred Equity
- - - - - - - - 0.00 0.00 -333
Repurchase of Common Equity
- - - - - - - - 0.00 0.00 -8.00
Payment of Dividends
-1,660 -1,653 -1,393 -1,032 -1,208 -913 -907 -1,154 -1,322 -1,570 -1,742
Issuance of Debt
1,679 748 5.00 200 998 748 - 0.00 0.00 650 2,998
Issuance of Common Equity
1,099 796 1,664 0.00 128 - 1.00 26 106 57 75
Other Financing Activities, net
300 447 36 -778 325 -148 -167 - - - 1,100
Cash Interest Paid
405 462 486 400 397 428 401 393 377 351 431
Cash Income Taxes Paid
50 98 50 21 136 111 76 112 69 269 98

Quarterly Cash Flow Statements for Plains GP

This table details how cash moves in and out of Plains GP's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-119 222 85 -292 80 31 721 -866 -157 888 -180
Net Cash From Operating Activities
418 652 688 726 638 692 817 784 418 952 672
Net Cash From Continuing Operating Activities
418 652 688 726 428 391 804 614 400 811 672
Net Income / (Loss) Continuing Operations
336 317 300 117 356 283 223 305 325 164 392
Consolidated Net Income / (Loss)
336 317 300 117 492 283 504 407 222 1,815 432
Net Income / (Loss) Discontinued Operations
- - - - 136 - - 102 -103 1,651 40
Depreciation Expense
254 257 258 257 232 204 230 257 243 243 235
Non-Cash Adjustments To Reconcile Net Income
45 83 52 127 -2.00 -109 168 78 -15 58 120
Changes in Operating Assets and Liabilities, net
-217 -5.00 78 225 -158 13 183 -26 -153 346 -75
Net Cash From Investing Activities
-261 -157 -193 -264 -819 -274 -408 -1,938 -233 3,335 -99
Net Cash From Continuing Investing Activities
-261 -157 -193 -264 -767 -168 -363 -1,892 -217 -132 -128
Purchase of Property, Plant & Equipment
-157 -139 -157 -166 -140 -119 -185 -148 -130 -138 -139
Acquisitions
-91 -20 -33 -104 -624 -57 -184 -1,786 -88 -42 -20
Sale of Property, Plant & Equipment
3.00 3.00 2.00 5.00 3.00 18 6.00 54 3.00 1.00 31
Net Cash From Discontinued Investing Activities
- - - - -52 - -45 -46 -16 3,467 29
Net Cash From Financing Activities
-272 -271 -413 -746 262 -407 318 301 -339 -3,386 -752
Net Cash From Continuing Financing Activities
-272 -271 -413 -746 262 -407 318 301 -339 -3,386 -752
Repayment of Debt
103 -443 -31 -361 56 -6.00 -504 -1,162 112 -2,938 -77
Repurchase of Preferred Equity
0.00 - - - -333 - - - 0.00 - -1,687
Payment of Dividends
-387 -383 -398 -402 -463 -426 -431 -422 -451 -448 -488
Issuance of Debt
0.00 543 - - 998 - 1,248 752 0.00 - 1,500
Other Net Changes in Cash
-4.00 -2.00 3.00 -8.00 -1.00 20 -6.00 - -3.00 -13 -1.00
Cash Interest Paid
64 116 59 112 90 126 81 134 138 121 130
Cash Income Taxes Paid
86 107 43 33 27 21 32 18 28 25 2.00

Annual Balance Sheets for Plains GP

This table presents Plains GP's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
24,142 26,103 26,753 26,830 29,969 25,951 29,978 29,207 28,597 27,756 31,276
Total Current Assets
2,972 4,275 4,003 3,536 4,614 3,668 6,140 5,358 4,916 4,776 4,704
Cash & Equivalents
30 50 40 69 47 25 452 404 453 349 329
Accounts Receivable
1,785 2,279 3,029 2,454 3,614 2,553 4,705 3,907 3,760 3,679 3,598
Inventories, net
916 1,343 713 640 604 647 783 729 548 261 211
Other Current Assets
241 603 221 373 312 405 200 318 155 72 87
Other Current Nonoperating Assets
- - - - - - - - - 415 479
Plant, Property, & Equipment, net
13,493 13,890 14,105 14,802 15,367 14,620 14,909 15,253 15,782 13,446 16,860
Plant, Property & Equipment, gross
15,695 16,261 16,901 17,905 18,983 18,620 19,292 20,055 21,143 18,528 22,536
Accumulated Depreciation
2,202 2,371 2,796 3,103 3,616 4,000 4,383 4,802 5,361 5,082 5,676
Total Noncurrent Assets
7,677 7,938 8,645 7,188 9,988 7,663 23,838 8,596 7,899 9,534 9,712
Long-Term Investments
2,027 2,343 2,756 2,702 3,683 3,764 3,805 3,084 2,820 2,811 2,846
Intangible Assets
- - - - - 805 1,960 2,145 1,875 1,677 1,754
Noncurrent Deferred & Refundable Income Taxes
1,835 1,876 1,386 - 1,280 1,444 1,362 1,309 1,239 1,220 1,136
Other Noncurrent Operating Assets
1,410 1,375 1,937 1,965 2,485 1,650 16,711 2,058 1,965 1,477 1,419
Other Noncurrent Nonoperating Assets
- - - - - - - - - 2,349 2,557
Total Liabilities & Shareholders' Equity
24,142 26,103 26,753 26,830 29,969 25,951 29,978 29,207 28,597 27,756 31,276
Total Liabilities
14,908 15,396 14,395 23,564 15,484 14,761 15,801 14,569 13,625 13,440 17,060
Total Current Liabilities
3,409 4,666 4,533 3,458 5,019 4,255 6,234 5,893 5,005 4,924 4,902
Short-Term Debt
999 1,715 737 66 504 831 822 1,159 446 407 563
Accounts Payable
2,040 2,590 3,324 2,705 3,687 2,425 4,811 4,045 3,845 3,647 3,457
Other Current Liabilities
370 361 472 687 828 999 601 689 714 520 500
Other Current Nonoperating Liabilities
- - - - - - - - - 350 382
Total Noncurrent Liabilities
11,499 10,730 9,862 20,106 10,465 10,506 9,567 8,676 8,620 8,516 12,158
Long-Term Debt
11,499 10,730 9,862 10,053 9,187 9,382 8,398 7,287 7,305 7,211 10,696
Other Noncurrent Operating Liabilities
- - - 10,053 1,278 1,124 1,169 1,389 1,315 729 856
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - 576 606
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
9,234 10,707 12,358 11,473 14,485 11,190 14,177 14,638 14,972 14,316 14,216
Total Preferred & Common Equity
0.00 0.00 0.00 0.00 2,155 1,464 1,533 1,524 1,548 1,351 1,345
Total Common Equity
0.00 0.00 0.00 0.00 2,155 1,464 1,533 1,524 1,548 1,351 1,345
Common Stock
- - - - 2,155 1,464 1,533 1,524 1,548 1,351 1,345
Noncontrolling Interest
9,234 10,707 12,358 11,473 12,330 9,726 12,644 13,114 13,424 12,965 12,871

Quarterly Balance Sheets for Plains GP

This table presents Plains GP's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
28,167 28,997 28,590 28,667 28,357 28,252 28,300 29,252 32,760 30,233 30,498
Total Current Assets
4,660 5,333 5,004 5,380 5,160 4,729 4,658 5,577 6,158 6,530 6,943
Cash & Equivalents
936 262 334 556 641 429 460 1,181 172 1,060 880
Accounts Receivable
3,220 4,253 4,040 4,208 3,952 3,820 3,562 3,623 4,821 5,267 5,592
Inventories, net
367 617 453 502 436 335 151 184 380 84 343
Other Current Assets
137 201 177 114 131 145 100 155 183 119 128
Other Current Nonoperating Assets
- - - - - - 385 434 602 0.00 0.00
Plant, Property, & Equipment, net
15,222 15,590 15,671 15,616 15,651 16,062 14,177 14,143 16,873 16,781 16,757
Plant, Property & Equipment, gross
20,397 20,888 21,162 21,254 21,464 22,125 19,589 19,678 22,687 22,702 22,696
Accumulated Depreciation
5,175 5,298 5,491 5,638 5,813 6,063 5,412 5,535 5,814 5,921 5,939
Total Noncurrent Assets
8,285 8,074 7,915 7,671 7,546 7,461 9,465 9,532 9,729 6,922 6,798
Long-Term Investments
3,062 2,830 2,878 2,862 2,846 2,745 2,709 2,873 2,838 2,817 2,726
Intangible Assets
1,999 1,969 1,807 1,741 1,674 1,675 1,636 1,570 1,686 1,610 1,535
Noncurrent Deferred & Refundable Income Taxes
1,263 1,259 1,231 1,221 1,211 1,199 1,175 1,157 1,176 1,083 1,076
Other Noncurrent Operating Assets
1,961 2,016 1,999 1,847 1,815 1,842 1,463 1,453 1,492 1,412 1,461
Other Noncurrent Nonoperating Assets
- - - - - - 2,482 2,479 2,537 0.00 0.00
Total Liabilities & Shareholders' Equity
28,167 28,997 28,590 28,667 28,357 28,252 28,300 29,252 32,760 30,233 30,498
Total Liabilities
13,300 14,186 13,712 13,867 13,613 14,192 14,175 15,106 18,808 14,919 16,817
Total Current Liabilities
4,654 5,608 5,146 5,398 5,126 4,684 4,648 5,359 6,536 5,851 6,344
Short-Term Debt
709 710 554 765 765 478 475 1,010 420 9.00 9.00
Accounts Payable
3,296 4,146 3,992 4,016 3,675 3,725 3,364 3,584 4,928 4,942 5,642
Other Current Liabilities
649 752 600 617 686 481 496 482 627 746 568
Other Current Nonoperating Liabilities
- - - - - - 313 283 561 154 125
Total Noncurrent Liabilities
8,646 8,578 8,566 8,469 8,487 9,508 9,527 9,747 12,272 9,068 10,473
Long-Term Debt
7,288 7,296 7,308 7,211 7,212 8,204 8,204 8,439 10,956 8,432 9,911
Other Noncurrent Operating Liabilities
1,358 1,282 1,258 1,258 1,275 1,304 725 711 651 636 562
Other Noncurrent Nonoperating Liabilities
- - - - - - 598 597 665 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
14,867 14,811 14,878 14,800 14,744 14,060 14,125 14,146 13,952 15,314 13,681
Total Preferred & Common Equity
1,568 1,531 1,518 1,490 1,462 1,356 1,354 1,345 1,274 1,580 1,475
Total Common Equity
1,568 1,531 1,518 1,490 1,462 1,356 1,354 1,345 1,274 1,580 1,475
Common Stock
1,568 1,531 1,518 1,490 1,462 1,356 1,354 1,345 1,274 1,580 1,475
Noncontrolling Interest
13,299 13,280 13,360 13,310 13,282 12,704 12,771 12,801 12,678 13,734 12,206

Annual Metrics And Ratios for Plains GP

This table displays calculated financial ratios and metrics derived from Plains GP's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 197,888,124.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 197,888,124.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.31
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
1,027 885 -52 1,987 1,824 -1,668 710 1,060 1,325 984 1,334
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.59% 5.83% 4.49% 5.24%
Earnings before Interest and Taxes (EBIT)
1,251 1,023 1,116 2,265 2,004 -2,344 861 1,065 1,603 1,189 1,449
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,684 1,538 1,635 2,786 2,608 -1,688 1,638 2,033 2,654 2,215 2,402
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-333 -199 546 12,838 -9,275 1,165 -15,763 15,513 1,471 1,657 -1,982
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
19,675 20,759 20,161 9,310 20,409 17,576 34,049 19,596 19,450 18,777 20,252
Increase / (Decrease) in Invested Capital
1,360 1,084 -598 -10,851 11,099 -2,833 16,473 -14,453 -146 -673 3,316
Book Value per Share
$0.00 $0.00 $0.00 $0.00 $11.84 $7.80 $7.90 $7.84 $7.88 $6.84 $6.80
Tangible Book Value per Share
($10.59) ($8.73) ($16.57) ($15.84) ($2.12) $3.51 ($2.20) ($3.20) ($1.66) ($1.65) ($2.07)
Total Capital
21,732 23,152 22,957 21,592 24,176 21,403 23,397 23,084 22,723 21,937 25,475
Total Debt
12,498 12,445 10,599 10,119 9,691 10,213 9,220 8,446 7,751 7,621 11,259
Total Long-Term Debt
11,499 10,730 9,862 10,053 9,187 9,382 8,398 7,287 7,305 7,213 10,696
Net Debt
10,441 10,052 7,803 7,348 5,924 6,386 4,963 4,958 4,478 4,461 8,084
Capital Expenditures (CapEx)
2,074 680 -59 300 1,104 309 -545 395 231 606 562
Debt-free, Cash-free Net Working Capital (DFCFNWC)
532 1,274 167 75 15 181 276 220 -96 -89 36
Debt-free Net Working Capital (DFNWC)
562 1,324 207 144 99 244 728 624 357 260 365
Net Working Capital (NWC)
-437 -391 -530 78 -405 -587 -94 -535 -89 -148 -198
Net Nonoperating Expense (NNE)
218 225 -11 -120 -238 772 110 -103 -100 -86 -352
Net Nonoperating Obligations (NNO)
10,441 10,052 7,803 -2,163 5,924 6,386 19,872 4,958 4,478 4,461 6,036
Total Depreciation and Amortization (D&A)
433 515 519 521 604 656 777 968 1,051 1,026 953
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.97 ($3.06) $0.31 $0.86 $1.01 $0.52 $1.31
Adjusted Weighted Average Basic Shares Outstanding
91.70M 103.27M 157.01M 159.49M 168M 186M 194M 194M 195M 197M 198M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.96 ($3.07) $0.31 $0.86 $1.01 $0.52 $1.30
Adjusted Weighted Average Diluted Shares Outstanding
91.70M 103.27M 157.01M 159.49M 170M 246M 194M 194M 195M 197M 233M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
91.70M 103.27M 157.01M 159.49M 182.14M 194.10M 194.19M 194.41M 197.12M 197.74M 197.90M
Normalized Net Operating Profit after Tax (NOPAT)
1,027 867 879 1,887 1,850 596 1,208 1,282 1,191 1,119 1,283
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Plains GP

This table displays calculated financial ratios and metrics derived from Plains GP's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 197,888,124.00 197,904,124.00 197,904,124.00 197,904,124.00
DEI Adjusted Shares Outstanding
- - - - - - - 197,888,124.00 197,904,124.00 197,904,124.00 197,904,124.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.32 0.10 1.97 0.34
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.80% 11.47% 5.57% -2.33% 0.13% -16.58% -7.05% - 8.65% 66.26% 31.05%
EBITDA Growth
-21.97% -2.75% 24.54% -51.54% 29.45% -15.76% 63.34% - 6.41% 38.62% 7.10%
EBIT Growth
-31.96% -3.80% 53.45% -79.82% 47.80% -27.51% 131.22% - 7.48% 71.84% 9.49%
NOPAT Growth
-14.13% -6.11% 23.74% -83.59% 36.01% -18.15% 153.75% - 20.75% -20.28% 6.49%
Net Income Growth
-24.15% -5.11% 12.31% -69.29% 46.43% -10.44% 67.44% - -54.88% 541.34% -14.29%
EPS Growth
-40.00% -20.00% 13.33% -123.08% 100.00% -21.05% 141.18% - -76.19% 1,213.33% -139.02%
Operating Cash Flow Growth
-43.67% -26.49% 728.92% -28.12% 52.63% 6.14% 18.75% - -34.48% 37.57% -17.75%
Free Cash Flow Firm Growth
202.52% -319.02% 161.19% 42.28% -97.21% 952.95% 225.52% - -255.28% -214.63% -197.89%
Invested Capital Growth
-43.16% 2.61% -2.49% -3.46% 0.20% -8.67% -8.97% - 4.28% 13.31% 14.92%
Revenue Q/Q Growth
-5.54% 7.82% -1.47% -2.68% -3.15% -11.40% 8.80% - 24.31% 41.88% -14.24%
EBITDA Q/Q Growth
-13.45% 3.07% -3.61% -43.65% 131.21% -43.88% 56.79% - 40.53% 5.23% 13.55%
EBIT Q/Q Growth
-17.46% 4.40% -6.32% -75.00% 504.49% -54.46% 93.47% - 102.08% 8.51% 23.28%
NOPAT Q/Q Growth
-7.85% -11.51% -2.94% -79.27% 663.95% -52.42% 104.75% - 87.98% -55.32% 173.51%
Net Income Q/Q Growth
-11.81% -5.95% -4.75% -61.13% 320.51% -42.48% 78.09% - -45.45% 717.57% -76.20%
EPS Q/Q Growth
-19.23% -4.76% -15.00% -135.29% 800.00% -64.29% 173.33% - -68.75% 1,870.00% -108.12%
Operating Cash Flow Q/Q Growth
-58.61% 55.98% 5.52% 5.52% -12.12% 8.46% 18.06% - -46.68% 127.75% -29.41%
Free Cash Flow Firm Q/Q Growth
2,842.09% -101.26% 511.13% -6.37% -42.31% 348.76% 14.63% - 85.72% -390.73% 2.11%
Invested Capital Q/Q Growth
0.40% -0.87% -0.64% -2.38% 4.21% -9.65% -0.97% - 0.76% -1.83% 0.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
8.99% 8.31% 9.31% 9.47% 10.41% 8.31% 8.58% - 7.83% 6.43% 7.53%
EBITDA Margin
5.15% 4.93% 4.82% 2.79% 6.66% 4.22% 6.08% - 5.06% 3.75% 4.97%
Operating Margin
3.08% 2.88% 2.72% 0.69% 4.43% 2.23% 4.17% - 3.23% 2.24% 3.39%
EBIT Margin
3.03% 2.94% 2.79% 0.72% 4.48% 2.30% 4.09% - 3.11% 2.38% 3.42%
Profit (Net Income) Margin
2.80% 2.44% 2.36% 0.94% 4.10% 2.66% 4.35% - 1.78% 10.26% 2.85%
Tax Burden Percent
92.31% 81.03% 84.55% 71.34% 87.08% 123.58% 110.04% - 66.67% 484.00% 102.86%
Interest Burden Percent
100.00% 102.63% 100.00% 184.27% 105.02% 93.47% 96.62% - 85.82% 89.07% 80.92%
Effective Tax Rate
7.69% 18.97% 15.45% 28.66% 12.92% 6.99% 6.55% - 2.40% 55.73% 6.67%
Return on Invested Capital (ROIC)
5.10% 6.06% 5.94% 1.28% 9.88% 5.37% 9.99% - 7.14% 2.76% 9.41%
ROIC Less NNEP Spread (ROIC-NNEP)
5.06% 6.40% 6.12% 2.54% 10.45% 6.91% 11.33% - 4.28% 42.39% 8.42%
Return on Net Nonoperating Assets (RNNOA)
4.14% 1.85% 1.95% 0.78% 3.67% 1.94% 3.08% - 1.83% 11.91% 2.97%
Return on Equity (ROE)
9.24% 7.91% 7.88% 2.06% 13.55% 7.30% 13.07% - 8.97% 14.67% 12.38%
Cash Return on Invested Capital (CROIC)
59.76% 3.97% 9.21% 8.67% 5.47% 14.78% 16.62% - 2.82% -5.33% -6.60%
Operating Return on Assets (OROA)
5.12% 5.14% 4.91% 1.28% 7.89% 3.88% 6.69% - 4.62% 4.25% 6.40%
Return on Assets (ROA)
4.73% 4.27% 4.15% 1.68% 7.22% 4.48% 7.12% - 2.64% 18.33% 5.33%
Return on Common Equity (ROCE)
0.95% 0.82% 0.80% 0.20% 1.35% 0.72% 1.27% - 0.84% 1.46% 1.25%
Return on Equity Simple (ROE_SIMPLE)
86.82% 87.32% 91.24% 0.00% 90.41% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
341 301 293 61 463 220 451 209 393 176 481
NOPAT Margin
2.84% 2.33% 2.30% 0.49% 3.86% 2.07% 3.90% - 3.15% 0.99% 3.17%
Net Nonoperating Expense Percent (NNEP)
0.04% -0.34% -0.18% -1.26% -0.57% -1.54% -1.34% - 2.86% -39.63% 0.99%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.28% 2.04% 0.97% 1.91% 0.82% 1.55% 0.74% 2.04%
Cost of Revenue to Revenue
91.01% 91.69% 90.69% 90.53% 89.59% 91.69% 91.42% - 92.17% 93.57% 92.47%
SG&A Expenses to Revenue
3.79% 3.44% 4.57% 5.43% 3.90% 3.48% 3.21% - 3.08% 2.48% 2.54%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.91% 5.44% 6.59% 8.78% 5.98% 6.08% 4.40% - 4.60% 4.18% 4.14%
Earnings before Interest and Taxes (EBIT)
364 380 356 89 538 245 474 192 388 421 519
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
618 637 614 346 800 449 704 449 631 664 754
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.29 2.45 2.45 2.64 3.05 2.78 2.62 - 3.71 2.99 3.42
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.07 0.07 0.07 0.07 0.08 0.08 0.07 - 0.10 0.09 0.09
Price to Earnings (P/E)
20.35 22.54 21.59 34.63 28.54 27.71 18.98 - 24.10 8.52 9.35
Dividend Yield
6.34% 6.32% 6.72% 7.03% 6.37% 7.32% 8.17% - 0.00% 1.75% 3.27%
Earnings Yield
4.91% 4.44% 4.63% 2.89% 3.50% 3.61% 5.27% - 4.15% 11.74% 10.69%
Enterprise Value to Invested Capital (EV/IC)
1.10 1.11 1.11 1.12 1.14 1.25 1.24 - 1.26 1.15 1.17
Enterprise Value to Revenue (EV/Rev)
0.44 0.43 0.42 0.42 0.45 0.46 0.46 - 0.57 0.44 0.42
Enterprise Value to EBITDA (EV/EBITDA)
8.67 8.74 8.27 9.48 9.32 9.53 8.40 - 10.56 8.77 8.81
Enterprise Value to EBIT (EV/EBIT)
15.01 15.19 13.86 17.66 16.40 17.36 14.12 - 17.46 13.94 13.89
Enterprise Value to NOPAT (EV/NOPAT)
16.92 17.22 16.39 21.33 20.14 20.84 16.37 - 18.39 17.07 17.21
Enterprise Value to Operating Cash Flow (EV/OCF)
8.96 9.95 7.72 8.45 8.27 8.04 7.56 - 9.50 7.75 8.34
Enterprise Value to Free Cash Flow (EV/FCFF)
1.33 28.39 11.90 12.67 20.89 8.06 7.12 - 45.68 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.53 0.54 0.54 0.53 0.62 0.61 0.67 - 0.82 0.55 0.73
Long-Term Debt to Equity
0.49 0.49 0.49 0.50 0.58 0.58 0.60 - 0.79 0.55 0.72
Financial Leverage
0.82 0.29 0.32 0.31 0.35 0.28 0.27 - 0.43 0.28 0.35
Leverage Ratio
1.93 1.92 1.94 1.92 1.96 1.97 1.99 - 2.18 1.99 2.15
Compound Leverage Factor
1.93 1.97 1.94 3.55 2.06 1.84 1.93 - 1.87 1.77 1.74
Debt to Total Capital
34.57% 35.02% 35.11% 34.74% 38.18% 38.06% 40.05% - 44.91% 35.53% 42.03%
Short-Term Debt to Total Capital
2.44% 3.36% 3.37% 1.86% 2.10% 2.08% 4.28% - 1.66% 0.04% 0.04%
Long-Term Debt to Total Capital
32.14% 31.66% 31.74% 32.88% 36.07% 35.98% 35.77% - 43.26% 35.50% 41.99%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
58.75% 58.44% 58.46% 59.10% 55.86% 56.00% 54.25% - 50.06% 57.82% 51.72%
Common Equity to Total Capital
6.68% 6.54% 6.43% 6.16% 5.96% 5.94% 5.70% - 5.03% 6.65% 6.25%
Debt to EBITDA
3.17 3.24 3.09 3.44 3.62 3.75 3.65 - 4.66 3.22 3.71
Net Debt to EBITDA
1.88 1.85 1.74 2.01 2.30 2.38 2.09 - 3.43 1.74 2.36
Long-Term Debt to EBITDA
2.95 2.93 2.79 3.26 3.42 3.55 3.26 - 4.49 3.21 3.71
Debt to NOPAT
6.19 6.38 6.12 7.74 7.82 8.20 7.12 - 8.12 6.26 7.24
Net Debt to NOPAT
3.66 3.65 3.45 4.53 4.96 5.21 4.06 - 5.97 3.38 4.61
Long-Term Debt to NOPAT
5.75 5.77 5.54 7.33 7.39 7.76 6.36 - 7.82 6.25 7.24
Altman Z-Score
1.88 1.93 1.98 1.97 2.01 1.88 1.81 - 1.56 1.99 2.09
Noncontrolling Interest Sharing Ratio
89.67% 89.69% 89.87% 90.10% 90.07% 90.17% 90.28% - 90.61% 90.03% 89.87%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.97 1.00 1.01 0.97 1.01 1.00 1.04 - 0.94 1.12 1.09
Quick Ratio
0.85 0.88 0.90 0.86 0.91 0.87 0.90 - 0.76 1.08 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
15,171 -191 784 734 423 1,899 2,177 -3,107 -444 -2,177 -2,131
Operating Cash Flow to CapEx
271.43% 479.41% 443.87% 450.93% 339.36% 685.15% 456.42% - 329.13% 694.89% 622.22%
Free Cash Flow to Firm to Interest Expense
159.69 -1.99 8.08 7.80 3.96 17.27 19.44 - -3.08 -16.13 -18.37
Operating Cash Flow to Interest Expense
4.40 6.79 7.09 7.72 5.96 6.29 7.29 - 2.90 7.05 5.79
Operating Cash Flow Less CapEx to Interest Expense
2.78 5.38 5.49 6.01 4.21 5.37 5.70 - 2.02 6.04 4.86
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.69 1.75 1.76 1.78 1.76 1.68 1.64 - 1.48 1.79 1.87
Accounts Receivable Turnover
12.08 13.38 12.28 13.07 12.75 12.35 12.43 - 10.47 11.85 12.13
Inventory Turnover
96.34 104.58 87.16 92.32 115.24 132.69 136.67 - 115.83 410.27 196.02
Fixed Asset Turnover
3.13 3.22 3.22 3.21 3.16 3.22 3.16 - 2.75 3.38 3.62
Accounts Payable Turnover
11.03 12.43 11.74 11.79 11.77 11.74 11.67 - 9.57 11.61 11.20
Days Sales Outstanding (DSO)
30.22 27.28 29.73 27.92 28.64 29.56 29.35 - 34.85 30.81 30.08
Days Inventory Outstanding (DIO)
3.79 3.49 4.19 3.95 3.17 2.75 2.67 - 3.15 0.89 1.86
Days Payable Outstanding (DPO)
33.10 29.37 31.10 30.95 31.02 31.09 31.27 - 38.14 31.44 32.60
Cash Conversion Cycle (CCC)
0.91 1.40 2.81 0.93 0.79 1.22 0.76 - -0.14 0.25 -0.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
19,528 19,358 19,234 18,777 19,568 17,679 17,508 20,252 20,405 20,032 20,120
Invested Capital Turnover
1.80 2.60 2.59 2.62 2.56 2.59 2.56 - 2.26 2.77 2.97
Increase / (Decrease) in Invested Capital
-14,830 492 -491 -673 40 -1,679 -1,726 3,316 837 2,353 2,612
Enterprise Value (EV)
21,490 21,520 21,356 20,993 22,350 22,049 21,726 - 25,767 23,026 23,571
Market Capitalization
3,480 3,652 3,584 3,567 4,138 3,768 3,530 - 4,723 4,728 5,051
Book Value per Share
$7.70 $7.55 $7.41 $6.84 $6.86 $6.85 $6.80 $6.80 $6.44 $7.98 $7.45
Tangible Book Value per Share
($1.47) ($1.27) ($1.07) ($1.65) ($1.61) ($1.43) ($1.14) ($2.07) ($2.08) ($0.15) ($0.30)
Total Capital
22,740 22,776 22,721 21,937 22,742 22,804 23,595 25,475 25,328 23,755 23,601
Total Debt
7,862 7,976 7,977 7,621 8,682 8,679 9,449 11,259 11,376 8,441 9,920
Total Long-Term Debt
7,308 7,211 7,212 7,213 8,204 8,204 8,439 10,696 10,956 8,432 9,911
Net Debt
4,650 4,558 4,490 4,461 5,508 5,510 5,395 8,084 8,366 4,564 6,314
Capital Expenditures (CapEx)
154 136 155 161 188 101 179 94 127 137 108
Debt-free, Cash-free Net Working Capital (DFCFNWC)
78 191 158 -89 94 25 47 36 -130 -372 -272
Debt-free Net Working Capital (DFNWC)
412 747 799 260 523 485 1,228 365 42 688 608
Net Working Capital (NWC)
-142 -18 34 -148 45 10 218 -198 -378 679 599
Net Nonoperating Expense (NNE)
4.62 -15 -8.46 -56 -29 -63 -53 -198 171 -1,639 49
Net Nonoperating Obligations (NNO)
4,650 4,558 4,490 4,461 5,508 3,554 3,362 6,036 6,453 4,718 6,439
Total Depreciation and Amortization (D&A)
254 257 258 257 262 204 230 257 243 243 235
Debt-free, Cash-free Net Working Capital to Revenue
0.16% 0.38% 0.31% -0.18% 0.19% 0.05% 0.10% - -0.29% -0.71% -0.49%
Debt-free Net Working Capital to Revenue
0.85% 1.50% 1.59% 0.52% 1.04% 1.01% 2.61% - 0.09% 1.32% 1.09%
Net Working Capital to Revenue
-0.29% -0.04% 0.07% -0.30% 0.09% 0.02% 0.46% - -0.84% 1.30% 1.07%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.21 $0.20 $0.17 ($0.06) $0.42 $0.15 $0.42 $0.32 $0.10 $1.97 ($0.16)
Adjusted Weighted Average Basic Shares Outstanding
197M 197M 197M 197M 198M 198M 198M 198M 198M 198M 198M
Adjusted Diluted Earnings per Share
$0.21 $0.20 $0.17 ($0.06) $0.42 $0.15 $0.41 $0.32 $0.10 $1.97 ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding
197M 197M 197M 197M 198M 198M 233M 233M 197.90M 198M 198M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
197.25M 197.26M 197.47M 197.74M 197.74M 197.74M 197.89M 197.90M 197.90M 197.90M 198.10M
Normalized Net Operating Profit after Tax (NOPAT)
341 302 293 173 452 260 365 130 342 319 488
Normalized NOPAT Margin
2.84% 2.34% 2.30% 1.40% 3.76% 2.44% 3.16% - 2.74% 1.80% 3.22%
Pre Tax Income Margin
3.03% 3.02% 2.79% 1.32% 4.70% 2.15% 3.96% - 2.67% 2.12% 2.77%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.83 3.96 3.67 0.95 5.03 2.23 4.23 - 2.69 3.12 4.47
NOPAT to Interest Expense
3.59 3.14 3.02 0.65 4.33 2.00 4.03 - 2.73 1.30 4.14
EBIT Less CapEx to Interest Expense
2.21 2.54 2.07 -0.77 3.27 1.31 2.63 - 1.81 2.10 3.54
NOPAT Less CapEx to Interest Expense
1.96 1.72 1.42 -1.07 2.57 1.09 2.43 - 1.85 0.29 3.21
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
105.39% 111.61% 113.57% 146.73% 134.26% 141.58% 123.35% - 122.18% 59.70% 63.18%
Augmented Payout Ratio
105.39% 111.61% 113.57% 146.73% 134.26% 141.58% 123.35% - 122.18% 59.70% 63.18%

Financials Breakdown Chart

Key Financial Trends

Plains GP Holdings (NYSE:PAGP) delivered a sharply stronger second quarter, although much of the improvement came from discontinued operations. Revenue increased to $17.69 billion in Q2 2026 from $10.64 billion in the restated year-ago quarter, while gross profit rose to $1.14 billion from $884 million. However, the gross margin narrowed to approximately 6.4% from 8.3%, reflecting the company’s low-margin, high-volume business model.

Operating income was $397 million, down from $403 million in Q1 2026 but up from $237 million in Q2 2025. Operating expenses increased to $740 million, including a $59 million impairment charge. Selling, general and administrative expense also rose year over year to $439 million from $370 million, limiting the benefit of higher revenue.

Net income attributable to common shareholders surged to $389 million, or $1.97 per share, compared with $30 million, or $0.15 per share, in Q2 2025. The increase was driven primarily by $1.65 billion of income from discontinued operations. Continuing-operations income attributable to common shareholders was substantially lower than consolidated net income, highlighting the importance of separating one-time or divestiture-related gains from ongoing earnings power.

Cash generation improved in the latest quarter. Net cash from operating activities rose to $952 million from $692 million in Q2 2025, with continuing operating cash flow increasing to $811 million from $391 million. Operating working capital provided a $346 million benefit in Q2 2026, reversing the $5 million use of cash recorded in Q2 2025.

Investing cash flow was strongly positive at $3.34 billion, but this was almost entirely attributable to $3.47 billion from discontinued investing activities. Continuing operations used $132 million for investing, including $138 million of capital spending and $42 million for acquisitions. Financing cash flow was negative $3.39 billion, primarily because Plains repaid $2.94 billion of debt and paid $448 million in dividends.

The balance sheet improved compared with Q1 2026 and Q2 2025. Cash increased to $1.06 billion from $172 million at the end of Q1, while total debt declined to approximately $8.44 billion from $8.68 billion in Q2 2025. Total liabilities represented roughly 49% of assets at the end of Q2 2026, down modestly from about 50% a year earlier. The current ratio also improved to approximately 1.12 from about 1.00.

  • Higher operating cash flow: Q2 2026 operating cash flow reached $952 million, up 38% year over year, while continuing-oper­ations cash flow more than doubled.
  • Meaningful debt reduction: Plains repaid $2.94 billion of debt during the quarter, reducing total debt to approximately $8.44 billion.
  • Improved liquidity: Cash rose to $1.06 billion from $172 million in Q1 2026, and the current ratio moved above 1.0.
  • Stronger common-shareholder results: Earnings attributable to common shareholders increased to $389 million, or $1.97 per share, from $30 million, or $0.15 per share, in the restated year-ago period.
  • Continuing investment remained controlled: Continuing-operations capital spending was $138 million in Q2, below the $217 million spent on continuing investing activities in Q1 2026.
  • Revenue growth was accompanied by lower margins: Revenue rose approximately 66% year over year, but gross margin declined to about 6.4% from 8.3%.
  • Large noncontrolling interest: Noncontrolling interests totaled $13.73 billion, meaning consolidated earnings do not flow directly to PAGP common shareholders.
  • Discontinued operations dominated the earnings improvement: The $1.65 billion gain from discontinued operations accounted for most of the quarter’s consolidated net income and may not recur.
  • Higher operating costs: SG&A increased to $439 million from $370 million year over year, while total operating expenses reached $740 million.
  • Dividend and debt obligations consumed substantial cash: Plains paid $448 million in dividends and repaid nearly $3 billion of debt, producing negative financing cash flow of $3.39 billion.
11/14/26 10:51 AM ETAI Generated. May Contain Errors.

Plains GP Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Plains GP's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Plains GP's net income appears to be on an upward trend, with a most recent value of $1.69 billion in 2025, rising from $809 million in 2015. The previous period was $1.07 billion in 2024. See where experts think Plains GP is headed by visiting Plains GP's forecast page.

Plains GP's total operating income in 2025 was $1.43 billion, based on the following breakdown:
  • Total Gross Profit: $3.83 billion
  • Total Operating Expenses: $2.40 billion

Over the last 10 years, Plains GP's total revenue changed from $23.15 billion in 2015 to $44.26 billion in 2025, a change of 91.2%.

In the past 13 quarters, Plains GP's cash and equivalents has ranged from $172 million in Q1 2026 to $1.18 billion in Q3 2025, and is currently $880 million as of their latest financial filing in Q3 2026.

Plains GP had total debt of $11.26 billion at the end of 2025, a 47.7% increase from 2024, and a 9.9% decrease since 2015.

Over the last 10 years, Plains GP's book value per share changed from 0.00 in 2015 to 6.80 in 2025, a change of 679.7%.



Financial statements for NYSE:PAGP last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners